Raleigh, NC (December 4, 2009) – Robert Rehm, a partner in Smith Anderson’s Intellectual Property Practice Group, presented at a meeting of the Patent Law Committee of the Intellectual Property Law Section of the North Carolina Bar Association. The meeting was held on Wednesday, December 2, at the North Carolina Bar Center in Cary.
Rehm spoke on the statutory written description and enablement requirements for patentability that the disclosure in a U.S. patent application must meet. In particular, he discussed how those requirements factor into the United States Court of Appeals for the Federal Circuit's recent panel decision in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., which is scheduled for rehearing en banc on December 7, 2009. The outcome of the case will likely affect how patent applications are prepared and examined and how patents are litigated going forward. Jason Brege, a lawyer in Smith Anderson’s Intellectual Property Practice Group, provided research assistance for Rehm's presentation.
About Smith Anderson
Smith Anderson is the largest Triangle-based law firm and one of the largest in North Carolina. Representing diverse organizations with local, state, national and international interests, our lawyers focus on building and strengthening relationships by understanding our clients' businesses and customizing our legal solutions accordingly. Our commitment to our clients also extends to our community and profession.